Stock listing

BEAM Stock Price, News, Filings & Events — Beam Therapeutics Inc.

Selected listing: BEAM · NASDAQ · USD · US

BEAM:NASDAQ is the public listing for Beam Therapeutics Inc., a company with a market capitalization of approximately $2.58 billion. Beam Therapeutics specializes in creating precision genetic medicines aimed at treating a range of diseases. The company is actively engaged in research and development, contributing to advancements in genetic therapies. Recent news and filings may provide insights into their ongoing projects and market positioning.